Page last updated: 2024-11-07

n(8)-acetylspermidine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

N(8)-acetylspermidine : An acetylspermidine that is 1,8-diamino-4-azaoctane in which one of the hydrogens of the amino group attached to C-8 is replaced by an acetyl group. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID123689
CHEMBL ID78630
CHEBI ID27911
SCHEMBL ID183049
MeSH IDM0095777

Synonyms (27)

Synonym
CHEMBL78630
CMAP_000056
13431-24-8
n8-acetylspermidine
C01029
n-{4-[(3-aminopropyl)amino]butyl}acetamide
n(8)-monoacetylspermidine
CHEBI:27911 ,
n(8)-acetylspermidine
KBIO3_002944
KBIOGR_002466
KBIO2_005034
KBIO2_002466
KBIOSS_002473
KBIO2_007602
n-[4-(3-aminopropylamino)butyl]acetamide
q9c ,
acetamide, n-(4-((3-aminopropyl)amino)butyl)-
n8-acetylspermidine dihydrochloride
SCHEMBL183049
acetamide, n-[4-[(3-aminopropyl)amino]butyl]-
FONIWJIDLJEJTL-UHFFFAOYSA-N
DTXSID60158637
n-[4-[(3-aminopropyl)amino]butyl]-acetamide
acetylspermidine
n-(4-((3-aminopropyl)amino)butyl)acetamide
Q3869341
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (2)

RoleDescription
human metaboliteAny mammalian metabolite produced during a metabolic reaction in humans (Homo sapiens).
Escherichia coli metaboliteAny bacterial metabolite produced during a metabolic reaction in Escherichia coli.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
acetylspermidine
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (1)

PathwayProteinsCompounds
S-Adenosyl-L-Methionine Biosynthesis817

Protein Targets (1)

Other Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (5)

Processvia Protein(s)Taxonomy
putrescine biosynthetic processPeroxisomal N(1)-acetyl-spermine/spermidine oxidaseHomo sapiens (human)
putrescine catabolic processPeroxisomal N(1)-acetyl-spermine/spermidine oxidaseHomo sapiens (human)
spermidine catabolic processPeroxisomal N(1)-acetyl-spermine/spermidine oxidaseHomo sapiens (human)
spermine catabolic processPeroxisomal N(1)-acetyl-spermine/spermidine oxidaseHomo sapiens (human)
positive regulation of spermidine biosynthetic processPeroxisomal N(1)-acetyl-spermine/spermidine oxidaseHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (6)

Processvia Protein(s)Taxonomy
polyamine oxidase activityPeroxisomal N(1)-acetyl-spermine/spermidine oxidaseHomo sapiens (human)
N(1),N(12)-diacetylspermine:oxygen oxidoreductase (3-acetamidopropanal-forming) activityPeroxisomal N(1)-acetyl-spermine/spermidine oxidaseHomo sapiens (human)
spermine:oxygen oxidoreductase (spermidine-forming) activityPeroxisomal N(1)-acetyl-spermine/spermidine oxidaseHomo sapiens (human)
spermidine:oxygen oxidoreductase (3-aminopropanal-forming) activityPeroxisomal N(1)-acetyl-spermine/spermidine oxidaseHomo sapiens (human)
N1-acetylspermine:oxygen oxidoreductase (3-acetamidopropanal-forming) activityPeroxisomal N(1)-acetyl-spermine/spermidine oxidaseHomo sapiens (human)
N1-acetylspermidine:oxygen oxidoreductase (3-acetamidopropanal-forming) activityPeroxisomal N(1)-acetyl-spermine/spermidine oxidaseHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (2)

Processvia Protein(s)Taxonomy
peroxisomal matrixPeroxisomal N(1)-acetyl-spermine/spermidine oxidaseHomo sapiens (human)
cytosolPeroxisomal N(1)-acetyl-spermine/spermidine oxidaseHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (2)

Assay IDTitleYearJournalArticle
AID144350Inhibition of [acetyl-3H]-N8-Acetylspermidine deacetylase in rat liver1989Journal of medicinal chemistry, May, Volume: 32, Issue:5
Design and synthesis of inhibitors of N8-acetylspermidine deacetylase.
AID144351In vitro inhibition of N8-Acetylspermidine deacetylase from rat liver cytosol1992Journal of medicinal chemistry, Jun-26, Volume: 35, Issue:13
Inhibition of N8-acetylspermidine deacetylase by active-site-directed metal coordinating inhibitors.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (44)

TimeframeStudies, This Drug (%)All Drugs %
pre-199023 (52.27)18.7374
1990's14 (31.82)18.2507
2000's2 (4.55)29.6817
2010's4 (9.09)24.3611
2020's1 (2.27)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 10.78

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index10.78 (24.57)
Research Supply Index3.85 (2.92)
Research Growth Index4.63 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (10.78)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other46 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]